Filter by: Subject

Results Per Page:

Filter by: Subject

Acute cerebellar ataxia (1)
Airway microbiota (1)
Anaemia (1)
Anti-CEP-1 (1)
Anti-citrullinated peptide (anti-CCP) (1)
Anti-citrullinated peptide antibodies (1)
Anti-citrullinated peptide antibodies (ACPAs) (1)
Anti-citrullinated peptide/protein antibodies (1)
Anti-cyclic citrullinated peptide antibodies (ACPA) (1)
Anti-MCV (1)
Anti-rheumatic drugs (1)
Anti-Sa (1)
Anticyclic citrullinated peptide antibodies (1)
Arm -- Diseases (1)
Arthralgia (1)
Arthritis (1)
Articular pain syndrome (1)
Atmospheric pollution (1)
Autoantibodies (1)
Autoantibody (1)
Biomarkers (1)
C-reactive protein (1)
Cardiovascular disease (CVD) (1)
Cardiovascular risk (1)
Children (1)
Chronic inflammation (2)
Cyclic citrullinated peptide antibody (1)
Cytokines (1)
Detection of synovitis (1)
Diagnosis (1)
Disease activity (1)
Disease activity score (1)
Disease modifying antirheumatic drugs (1)
Disease-modifying anti-rheumatic drugs (DMARDs) (1)
Diseases (1)
Drug-naıve patients (1)
Effects of drug treatment (1)
Efficacy (1)
Erosions (1)
Fluorescence analysis (1)
Functional disability (1)
Genetic predisposition (1)
Hand radiography (1)
Health-related quality of life (1)
Heavy metals (1)
Human immunodeficiency virus (HIV) (1)
Immune (1)
Immune dysregulation (1)
Immunogenicity (1)
Immunoglobulin A (1)
Immunoglobulin G antibody (1)
Inadequate response (1)
Inco-ordination (1)
Inflammatory (1)
Inflammatory biomarkers (1)
Intravenous abatacept (1)
Juvenile idiopathic arthritis (JIA) (1)
Laser nephelometry (1)
Leg -- Diseases (1)
Lower limb pain syndromes (1)
Magnetic resonance imaging (MRI) (1)
Matrix metalloproteinase-3( (1)
MCV antibody (1)
Medical rehabilitation (1)
Methotrexate (1)
Morbidity (1)
Pain (1)
Patients (1)
Peptidylarginine deiminases (1)
Periostitis (1)
Pharmacological therapy (1)
Poor appetite (1)
Predictive value (1)
Prevalence (1)
Proteins (1)
Psoriatic arthritis (1)
Reactive arthritis (1)
Reiter syndrome (1)
Response to therapy (1)
Rheumatoid arthritis (4)